STOCK TITAN

ICON plc Schedules Fourth Quarter and Full Year 2024 Earnings Conference Call

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

ICON plc (NASDAQ: ICLR), a healthcare intelligence and clinical research organization, has scheduled its fourth quarter and full year 2024 earnings release for Wednesday, February 19, 2025, after market close. The company will host a conference call and webcast to discuss the financial results on Thursday, February 20, 2025, at 8:00am ET. A replay of the webcast will be available approximately one hour after the call concludes. Investors can access the webcast through the Events section of ICON's investor relations website.

ICON plc (NASDAQ: ICLR), un'organizzazione di ricerca clinica e intelligenza sanitaria, ha programmato il suo rilascio dei risultati finanziari del quarto trimestre e dell'intero anno 2024 per mercoledì 19 febbraio 2025, dopo la chiusura del mercato. L'azienda ospiterà una chiamata e un webcast per discutere i risultati finanziari giovedì 20 febbraio 2025, alle 8:00 ET. Una registrazione del webcast sarà disponibile circa un'ora dopo la conclusione della chiamata. Gli investitori possono accedere al webcast nella sezione Eventi del sito web delle relazioni con gli investitori di ICON.

ICON plc (NASDAQ: ICLR), una organización de investigación clínica e inteligencia en salud, ha programado su publicación de resultados del cuarto trimestre y del año completo 2024 para el miércoles 19 de febrero de 2025, después del cierre del mercado. La empresa llevará a cabo una llamada en conferencia y un webcast para discutir los resultados financieros el jueves 20 de febrero de 2025, a las 8:00 am ET. Una repetición del webcast estará disponible aproximadamente una hora después de que finalice la llamada. Los inversores pueden acceder al webcast a través de la sección de Eventos del sitio web de relaciones con inversores de ICON.

ICON plc (NASDAQ: ICLR), 의료 정보 및 임상 연구 기관은 2024년 4분기 및 연간 실적 발표를 2025년 2월 19일 수요일, 시장 마감 후에 계획했습니다. 이 회사는 2025년 2월 20일 목요일 오전 8시(ET)에 재정 결과를 논의하기 위해 컨퍼런스 콜 및 웹캐스트를 개최할 것입니다. 웹캐스트의 재생은 통화가 종료된 후 약 한 시간 후에 이용 가능할 것입니다. 투자자들은 ICON의 투자자 관계 웹사이트의 이벤트 섹션을 통해 웹캐스트에 접근할 수 있습니다.

ICON plc (NASDAQ: ICLR), une organisation de recherche clinique et d'intelligence santé, a prévu la publication de ses résultats pour le quatrième trimestre et l'année entière 2024 pour le mercredi 19 février 2025, après la clôture des marchés. L'entreprise organisera une conférence téléphonique et un webcast pour discuter des résultats financiers le jeudi 20 février 2025, à 8h00 ET. Un replay du webcast sera disponible environ une heure après la fin de l'appel. Les investisseurs peuvent accéder au webcast via la section Événements du site web des relations investisseurs d'ICON.

ICON plc (NASDAQ: ICLR), eine Organisation für klinische Forschung und Gesundheitsintelligenz, hat ihre Veröffentlichung der Ergebnisse für das vierte Quartal und das gesamte Jahr 2024 für Mittwoch, den 19. Februar 2025, nach Marktschluss angesetzt. Das Unternehmen wird am Donnerstag, den 20. Februar 2025, um 8:00 Uhr ET eine Telefonkonferenz und einen Webcast abhalten, um die Finanzergebnisse zu besprechen. Eine Wiederholung des Webcasts wird ungefähr eine Stunde nach Abschluss des Anrufs verfügbar sein. Investoren können über den Bereich Veranstaltungen der Investor-Relations-Website von ICON auf den Webcast zugreifen.

Positive
  • None.
Negative
  • None.

DUBLIN--(BUSINESS WIRE)-- ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announced that it will release financial results for the fourth quarter and full year 2024 results after the market closes on Wednesday, February 19, 2025. The company will hold a conference call and webcast to discuss its financial results and performance on Thursday, February 20, 2025 at 8:00am ET.

Any changes to these events and links to the live webcasts (where available) will be posted on the Investor section of our website under “Events”. A webcast replay of the conference call will be available approximately one hour following the conclusion of the call.

About ICON plc

ICON plc is a world-leading healthcare intelligence and clinical research organisation. From molecule to medicine, we advance clinical research providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organisations. We develop new innovations, drive emerging therapies forward and improve patient lives. With headquarters in Dublin, Ireland, ICON employed approximately 42,250 employees in 106 locations in 55 countries as at September 30, 2024. For further information about ICON, visit: www.iconplc.com.

This press release contains forward-looking statements, including statements about our financial guidance. These statements are based on management's current expectations and information currently available, including current economic and industry conditions. These statements are not guarantees of future performance or actual results, and actual results, developments and business decisions may differ from those stated in this press release. The forward-looking statements are subject to future events, risks, uncertainties and other factors that could cause actual results to differ materially from those projected in the statements, including, but not limited to, the ability to enter into new contracts, maintain client relationships, manage the opening of new offices and offering of new services, the integration of new business mergers and acquisitions, as well as other economic and global market conditions and other risks and uncertainties detailed from time to time in SEC reports filed by ICON, all of which are difficult to predict and some of which are beyond our control. For these reasons, you should not place undue reliance on these forward-looking statements when making investment decisions. The word "expected" and variations of such words and similar expressions are intended to identify forward-looking statements. Forward-looking statements are only as of the date they are made and we do not undertake any obligation to update publicly any forward-looking statement, either as a result of new information, future events or otherwise. More information about the risks and uncertainties relating to these forward-looking statements may be found in SEC reports filed by ICON, including its Form 20-F, F-1, F-4, S-8, F-3 and certain other reports, which are available on the SEC's website at http://www.sec.gov.

ICON/ICLR-G

Kate Haven Vice President Investor Relations +1888 381 7923

Source: ICON plc

FAQ

When will ICON plc (ICLR) release its Q4 and full year 2024 earnings?

ICON plc will release its Q4 and full year 2024 earnings after market close on Wednesday, February 19, 2025.

What time is ICON's (ICLR) Q4 2024 earnings conference call?

ICON's Q4 2024 earnings conference call is scheduled for Thursday, February 20, 2025, at 8:00am ET.

Where can I access ICON's (ICLR) Q4 2024 earnings webcast?

The earnings webcast can be accessed through the Events section of ICON's investor relations website.

When will the replay of ICON's (ICLR) Q4 2024 earnings call be available?

The webcast replay will be available approximately one hour following the conclusion of the call.

Icon Plc

NASDAQ:ICLR

ICLR Rankings

ICLR Latest News

ICLR Stock Data

16.48B
81.85M
0.66%
101.13%
1.95%
Diagnostics & Research
Healthcare
Link
United States of America
Dublin